SYS-CON MEDIA Authors: Mat Mathews, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

Illumina to Announce Fourth Quarter and Fiscal Year 2013 Financial Results on Tuesday, January 28, 2014

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2013 following the close of market on Tuesday, January 28, 2014.

On the same day, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) Jay Flatley, Chief Executive Officer; Marc Stapley, Senior Vice President and Chief Financial Officer; Francis deSouza, President; and Christian Henry, Senior Vice President and Chief Commercial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Tuesday, January 28, 2014. Interested parties may listen to the call by dialing 888-713-4213 (passcode: 72154577), or if outside North America, by dialing +1-617-213-4865 (passcode: 72154577). Individuals may access the live teleconference in the Investor Relations section of Illumina's web site under the “Company” tab at www.illumina.com.

A replay of the conference call will be available from 6:00 p.m. Pacific Time (9:00 p.m. Eastern Time) on January 28, 2014 through February 4, 2014 by dialing 888-286-8010 (passcode: 88834345), or if outside North America, by dialing +1-617-801-6888 (passcode: 88834345).

About Illumina

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.